Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Development of Cell Culture Media for Cultivated Meat Production.

Advances in biochemical engineering/biotechnology·2025
Same author

Non-ammoniagenic proliferation and differentiation media for cultivated adipose tissue.

Frontiers in bioengineering and biotechnology·2023
Same author

Serum-free media for the growth of primary bovine myoblasts.

Cytotechnology·2019
Same author

The role of receptor MAS in microglia-driven retinal vascular development.

Angiogenesis·2019
Same author

Swinging beats: transient heart block in cardiac lymphoma.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2018
Same author

Combination of bone morphogenetic protein-2 plasmid DNA with chemokine CXCL12 creates an additive effect on bone formation onset and volume.

European cells & materials·2015

相关实验视频

Updated: Jul 19, 2026

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery
09:41

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery

Published on: December 23, 2014

金属蛋白酶抑制减少了气球血管造形术后的收缩性动脉重塑:在动脉样硬化尤卡坦微型小猪中进行的一项研究.

B J de Smet1, D de Kleijn, R Hanemaaijer

  • 1Heart Lung Institute, Utrecht University Hospital, and the Interuniversity Cardiology Institute of The Netherlands, Utrecht, The Netherlands.

Circulation
|June 28, 2000
PubMed
概括

巴蒂马斯塔特是一种矩阵金属蛋白酶 (MMP) 抑制剂,在气球血管造形术后显著降低了晚期光线损失和动脉重塑. 然而,它没有抑制neointima形成,这表明MMPs在重塑中起作用,但不一定在血管形成术后的细胞增殖中起作用.

更多相关视频

Porcine Model of Infrarenal Abdominal Aortic Aneurysm
11:13

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Published on: November 21, 2019

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

相关实验视频

Last Updated: Jul 19, 2026

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery
09:41

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery

Published on: December 23, 2014

Porcine Model of Infrarenal Abdominal Aortic Aneurysm
11:13

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Published on: November 21, 2019

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

科学领域:

  • 心血管研究研究心血管研究
  • 干预心脏病学 干预心脏病学
  • 血管生物学 血管生物学

背景情况:

  • 气球血管造形术后的动脉重塑是静脉缩的一个关键因素.
  • 在气球受伤后,矩阵金属蛋白酶 (MMP) 表达增加.
  • 原体代谢的扰乱可能会影响复原的结果.

研究的目的:

  • 调查巴蒂马斯塔特,一种非特异性MMP抑制剂,对晚期光线损失的影响.
  • 评估巴蒂马斯塔特在气球扩张后对动脉重塑和新内形成的影响.

主要方法:

  • 气球血管整形手术是在尤卡坦微猪的动脉样硬化阴道动脉上进行的.
  • 动物被随机分为Batimastat和载体组,接受腹腔内注射.
  • 血管内超声波和定量血管造影用于术前和术后以及42天后续评估.

主要成果:

  • 巴蒂马斯塔特显著降低了血管和声谱晚期光线损失 (0.3毫米 vs 0.8毫米) 和晚期介质边界面积损失 (0.9毫米2 vs 3.8毫米2).
  • 通过晚期介质边界面积损失测量动脉重塑,巴蒂马斯塔特显著抑制了动脉重塑 (P=0.003).
  • 新密度形成在巴蒂马斯塔特和载体组之间没有显著差异 (1.3 mm2对1.0 mm2,P=0.542).

结论:

  • 用巴蒂马斯塔特抑制矩阵金属蛋白酶有效地减少了气球血管造形术后的晚期光线损失.
  • 巴蒂马斯塔特抑制了收缩性动脉重塑,但并没有显著抑制新心形成.
  • 这些发现凸显了MMP在动脉重塑中的特定作用,而不是血管造形术后的neointima扩散.